Advertisement
U.S. Markets closed
S&P Futures
6,003.25 -0.50 (-0.01%) Dow Futures
43,915.00 +5.00 (+0.01%) Nasdaq Futures
21,219.00 -5.75 (-0.03%) Russell 2000 Futures
2,398.60 +2.90 (+0.12%) Crude Oil
72.12 -0.24 (-0.33%) Gold
2,708.70 +2.90 (+0.11%)
At close: 04:00PM EST
After hours:
| Previous Close | 10.32 |
| Open | 10.44 |
| Bid | 10.60 x 800 |
| Ask | 10.64 x 1600 |
| Day's Range | 10.28 - 10.71 |
| 52 Week Range | 2.57 - 13.85 |
| Volume | |
| Avg. Volume | 1,147,193 |
| Market Cap | 644.999M |
| Beta (5Y Monthly) | 1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.82 |
| Earnings Date | Oct 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.25 |
GlobeNewswireCorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
BERKELEY HEIGHTS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in the Truist Securities BioPharma Symposium, taking place in New York City on Thursday, November 7, 2024. Truist Securities BioPharma SymposiumDate:Thursday, November 7, 2024Format:1x1 meetingsLocation:Lotte New York Pal
Simply Wall St.Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
CorMedix Inc. ( NASDAQ:CRMD ) shareholders will have a reason to smile today, with the analysts making substantial...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.